Expression of the longest RGS4 splice variant in the prefrontal cortex is associated with single nucleotide polymorphisms in schizophrenia patients

Frontiers in Psychiatry

Volumn 7, Issue FEB, 2016, Pages

  Ding, Lan ^a   Styblo, Miroslav ^a   Drobná, Zuzana ^a   Hegde, Ashok N ^b,c  

^a University of North Carolina at Chapel Hill   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c GEORGIA COLLEGE AND STATE UNIVERSITY   (United States)

Author keywords

Allele; Bipolar disorder; Genotype; Postmortem; Psychiatric; Regulatory region

Indexed keywords

MESSENGER RNA; RGS4 PROTEIN;

ARTICLE; BINDING SITE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; DORSOLATERAL PREFRONTAL CORTEX; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HUMAN TISSUE; RGS4 GENE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84964627165     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2016.00026     Document Type: Article

References (46)

1. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry (2001) 6:293-301. doi:10.1038/sj.mp.4000866
2. Chowdari KV, Bamne M, Wood J, Talkowski ME, Mirnics K, Levitt P, et al. Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia. Schizophr Bull (2008) 34:118-26. doi:10.1093/schbul/sbm042
3. Bakker SC, Hoogendoorn ML, Hendriks J, Verzijlbergen K, Caron S, Verduijn W, et al. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes, Brain and Behav (2007) 6:113-9.
4. Chen X, Dunham C, Kendler S, Wang X, O'Neill FA, Walsh D, et al. Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am J Med Genet B Neuropsychiatr Genet (2004) 129:23-6. doi:10.1002/ajmg.b.30078
5. Cordeiro Q, Talkowski ME, Chowdari KV, Wood J, Nimgaonkar V, Vallada H. Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil. Genes Brain Behav (2005) 4:45-50. doi:10.1111/j.1601-183x.2004.00096.x
6. Morris DW, Rodgers A, McGhee KA, Schwaiger S, Scully P, Quinn J, et al. Confirming RGS4 as a susceptibility gene for schizophrenia. Am J Med Genet B Neuropsyhiatr Genet (2004) 125:50-3. doi:10.1002/ajmg.b.20109
7. Prasad KM, Chowdari KV, Nimgaonkar VL, Talkowski ME, Lewis DA, Keshavan MS. Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Mol Psychiatry (2005) 10:213-9. doi:10.1038/sj.mp.4001562
8. So HC, Chen RY, Chen EY, Cheung EF, Li T, Sham PC. An association study of RGS4 polymorphisms with clinical phenotypes of schizophrenia in a Chinese population. Am J Med Genet B Neuropsyhiatr Genet (2008) 147B:77-85. doi:10.1002/ajmg.b.30577
9. Campbell DB, Ebert PJ, Skelly T, Stroup TS, Lieberman J, Levitt P, et al. Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia. Biol Psychiatry (2008) 63:32-41. doi:10.1016/j.biopsych.2007.04.018
10. Lane HY, Liu YC, Huang CL, Chang YC, Wu PL, Huang CH, et al. RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia. J Clin Psychopharmacol (2008) 28:64-8. doi:10.1097/jcp.0b013e3181603f5a
11. Rethelyi JM, Bakker SC, Polgar P, Czobor P, Strengman E, Pasztor PI, et al. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. Am J Med Genet B Neuropsyhiatr Genet (2010) 153B:792-801. doi:10.1002/ajmg.b.31049
12. Ding L, Mychaleckyj JC, Hegde AN. Full length cloning and expression analysis of splice variants of regulator of G-protein signaling RGS4 in human and murine brain. Gene (2007) 401:46-60. doi:10.1016/j.gene.2007.07.002
13. Ding L, Hegde AN. Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients. Biol Psychiatry (2009) 65:541-5. doi:10.1016/j.biopsych.2008.10.026
14. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol (1987) 196:261-82. doi:10.1016/0022-2836(87)90689-9
15. Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A, et al. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A (2005) 102:9341-6. doi:10.1073/pnas.0503736102
16. Wu X, Rauch TA, Zhong X, Bennett WP, Latif F, Krex D, et al. CpG island hypermethylation in human astrocytomas. Cancer Res (2010) 70:2718-27. doi:10.1158/0008-5472.CAN-09-3631
17. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet (2001) 68:978-89. doi:10.1086/319501
18. Darst RP, Pardo CE, Ai L, Brown KD, Kladde MP. Bisulfite sequencing of DNA. Curr Protoc Mol Biol (2010) 7:Unit-17. doi:10.1002/0471142727.mb0709s91
19. Plowman SJ, Berry RL, Bader SA, Luo F, Arends MJ, Harrison DJ, et al. K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer. J Exp Clin Cancer Res (2006) 25:259-67.
20. Landry C, Clotman F, Hioki T, Oda H, Picard JJ, Lemaigre FP, et al. HNF-6 is expressed in endoderm derivatives and nervous system of the mouse embryo and participates to the cross-regulatory network of liver-enriched transcription factors. Dev Biol (1997) 192:247-57. doi:10.1006/dbio.1997.8757
21. Liu F, van den Broek O, Destree O, Hoppler S. Distinct roles for Xenopus Tcf/Lef genes in mediating specific responses to Wnt/beta-catenin signalling in mesoderm development. Development (2005) 132:5375-85. doi:10.1242/dev.02152
22. Galceran J, Miyashita-Lin EM, Devaney E, Rubenstein JL, Grosschedl R. Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. Development (2000) 127:469-82.
23. Wisniewska MB, Misztal K, Michowski W, Szczot M, Purta E, Lesniak W, et al. LEF1/beta-catenin complex regulates transcription of the Cav3.1 calcium channel gene (Cacna1g) in thalamic neurons of the adult brain. J Neurosci (2010) 30:4957-69. doi:10.1523/JNEUROSCI.1425-09.2010
24. Chung SH, Marzban H, Aldinger K, Dixit R, Millen K, Schuurmans C, et al. Zac1 plays a key role in the development of specific neuronal subsets in the mouse cerebellum. Neural Dev (2011) 6:25. doi:10.1186/1749-8104-6-25
25. Caiazzo M, Colucci-D'Amato L, Volpicelli F, Speranza L, Petrone C, Pastore L, et al. Krüppel-like factor 7 is required for olfactory bulb dopaminergic neuron development. Exp Cell Res (2011) 317:464-73. doi:10.1016/j.yexcr.2010.11.006
26. Vashishta A, Habas A, Pruunsild P, Zheng JJ, Timmusk T, Hetman M. Nuclear factor of activated T-cells isoform c4 (NFATc4/NFAT3) as a mediator of antiapoptotic transcription in NMDA receptor-stimulated cortical neurons. J Neurosci (2009) 29:15331-40. doi:10.1523/JNEUROSCI.4873-09.2009
27. Terzi D, Stergiou E, King SL, Zachariou V. Regulators of G protein signaling in neuropsychiatric disorders. Prog Mol Biol Transl Sci (2009) 86:299-333. doi:10.1016/S1877-1173(09)86010-9
28. Schwendt M, Sigmon SA, McGinty JF. RGS4 overexpression in the rat dorsal striatum modulates mGluR5-and amphetamine-mediated behavior and signaling. Psychopharmacology (Berl) (2012) 221:621-35. doi:10.1007/s00213-011-2606-8
29. Stratinaki M, Varidaki A, Mitsi V, Ghose S, Magida J, Dias C, et al. Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models. Proc Natl Acad Sci U S A (2013) 110:8254-9. doi:10.1073/pnas.1214696110
30. Meda SA, Jagannathan K, Gelernter J, Calhoun VD, Liu J, Stevens MC, et al. A pilot multivariate parallel ICA study to investigate differential linkage between neural networks and genetic profiles in schizophrenia. Neuroimage (2010) 53:1007-15. doi:10.1016/j.neuroimage.2009.11.052
31. Novak G, Gallo A, Zai CC, Meltzer HY, Lieberman JA, Potkin SG, et al. Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia. Psychiatr Genet (2010) 20:39-43. doi:10.1097/YPG.0b013e3283351221
32. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R, et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci U S A (2006) 103:6747-52. doi:10.1073/pnas.0602002103
33. Lipska BK, Mitkus S, Caruso M, Hyde TM, Chen J, Vakkalanka R, et al. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity. Hum Mol Genet (2006) 15:2804-12. doi:10.1093/hmg/ddl222
34. Horiuchi Y, Arai M, Niizato K, Iritani S, Noguchi E, Ohtsuki T, et al. A polymorphism in the PDLIM5 gene associated with gene expression and schizophrenia. Biol Psychiatry (2006) 59:434-9. doi:10.1016/j.biopsych.2005.07.041
35. Kao WT, Wang Y, Kleinman JE, Lipska BK, Hyde TM, Weinberger DR, et al. Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc Natl Acad Sci U S A (2010) 107:15619-24. doi:10.1073/pnas.1005410107
36. Jonsson EG, Saetre P, Nyholm H, Djurovic S, Melle I, Andreassen OA, et al. Lack of association between the regulator of G-protein signaling 4 (RGS4) rs951436 polymorphism and schizophrenia. Psychiatr Genet (2012) 22:263-4. doi:10.1097/YPG.0b013e32834f3558
37. Vilella E, Costas J, Sanjuan J, Guitart M, De DY, Carracedo A, et al. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J Psychiatr Res (2008) 42:278-88. doi:10.1016/j.jpsychires.2007.02.005
38. Schwab SG, Wildenauer DB. Update on key previously proposed candidate genes for schizophrenia. Curr Opin Psychiatry (2009) 22:147-53. doi:10.1097/YCO.0b013e328325a598
39. Vereczkei A, Mirnics K. Genetic predisposition to schizophrenia: what did we learn and what does the future hold? Neuropsychopharmacol Hung (2011) 13:205-10. doi:10.5706/nph201112003
40. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet (2005) 77:918-36. doi:10.1086/497703
41. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 10:40-68. doi:10.1038/sj.mp.4001630
42. Owen MJ, O'Donovan MC, Harrison PJ. Schizophrenia: a genetic disorder of the synapse? Br Med J (2005) 330:158-9. doi:10.1136/bmj.330.7484.158
43. Schwendt M, McGinty JF. Regulator of G-protein signaling 4 interacts with metabotropic glutamate receptor subtype 5 in rat striatum: relevance to amphetamine behavioral sensitization. J Pharmacol Exp Ther (2007) 323:650-57.
44. Min C, Cheong SY, Cheong SJ, Kim M, Cho DI, Kim KM. RGS4 exerts inhibitory activities on the signaling of dopamine D2 receptor and D3 receptor through the N-terminal region. Pharmacol Res (2012) 65:213-20. doi:10.1016/j.phrs.2011.08.008
45. Rahman Z, Schwarz J, Gold SJ, Zachariou V, Wein MN, Choi KH, et al. RGS9 modulates dopamine signaling in the basal ganglia. Neuron (2003) 38:941-52. doi:10.1016/S0896-6273(03)00321-0
46. Li Y, Zhao Q, Zhang Z, Wang P, Che R, Tang W, et al. Association study between RGS4 and bipolar disorder in the Chinese Han population. Psychiatr Genet (2010) 20:130-2. doi:10.1097/YPG.0b013e32833a2009